Tricyclic antidepressants (TCAs) such as amitriptyline and imipramine were initially prescribed for irritable bowel syndrome (IBS) patients with major depression. Today, they are commonly used to treat patients with severe or intractable IBS symptoms, which may have analgesic and neuromodulatory effects in addition to psychotropic effects.